Policy corpus
The coverage policies we hold
One row per policy: the contractor that issued it, the effective date CMS published, how many distinct versions of its text we have captured, and the CMS document. Every row links to its source. Nothing here is behind a login. The dated change feed is a different view of the same records.
1,097 local coverage determinations · page 11 of 11
| Policy | Title | Contractor | Effective | Versions held | Source |
|---|---|---|---|---|---|
| DL33930 | Proposed LCD DL33930: Facet Joint Interventions for Pain Management | First Coast | — | 1 | cms.gov ↗ |
| DL34356 | Proposed LCD DL34356: Erythropoiesis Stimulating Agents (ESA) | CGS Administrators | — | 1 | cms.gov ↗ |
| DL34410 | Proposed LCD DL34410: B-type Natriuretic Peptide (BNP) Testing | Palmetto GBA | — | 1 | cms.gov ↗ |
| DL34892 | Proposed LCD DL34892: Facet Joint Interventions for Pain Management | Novitas | — | 1 | cms.gov ↗ |
| DL35000 | Proposed LCD DL35000: Molecular Pathology Procedures | National Government Services | — | 1 | cms.gov ↗ |
| DL35010 | Proposed LCD DL35010: Trigger Point Injections | Novitas | — | 1 | cms.gov ↗ |
| DL35170 | Proposed LCD DL35170: Botulinum Toxin Injections | Noridian | — | 1 | cms.gov ↗ |
| DL35172 | Proposed LCD DL35172: Botulinum Toxin Injections | Noridian | — | 1 | cms.gov ↗ |
| DL36351 | Proposed LCD DL36351: Lab: Special Histochemical Stains and Immunohistochemical Stains | Noridian | — | 1 | cms.gov ↗ |
| DL36353 | Proposed LCD DL36353: Lab: Special Histochemical Stains and Immunohistochemical Stains | Noridian | — | 1 | cms.gov ↗ |
| DL36408 | Proposed LCD DL36408: Allergen Immunotherapy (AIT) with Subcutaneous Immunotherapy (SCIT) | WPS | — | 1 | cms.gov ↗ |
| DL37421 | Proposed LCD DL37421: Magnetic Resonance Image Guided High Intensity Focused Ultrasound (MRgFUS) for Tremor | National Government Services | — | 1 | cms.gov ↗ |
| DL38367 | Proposed LCD DL38367: Fluid Jet System Treatment for LUTS/BPH | National Government Services | — | 1 | cms.gov ↗ |
| DL38378 | Proposed LCD DL38378: Fluid Jet System in the Treatment of Benign Prostatic Hyperplasia (BPH) | CGS Administrators | — | 1 | cms.gov ↗ |
| DL38549 | Proposed LCD DL38549: Transurethral Waterjet Ablation of the Prostate | Palmetto GBA | — | 1 | cms.gov ↗ |
| DL38571 | Proposed LCD DL38571: Colon Capsule Endoscopy (CCE) | National Government Services | — | 1 | cms.gov ↗ |
| DL38682 | Proposed LCD DL38682: Transurethral Waterjet Ablation of the Prostate | WPS | — | 1 | cms.gov ↗ |
| DL38705 | Proposed LCD DL38705: Transurethral Waterjet Ablation of the Prostate | Noridian | — | 1 | cms.gov ↗ |
| DL38707 | Proposed LCD DL38707: Transurethral Waterjet Ablation of the Prostate | Noridian | — | 1 | cms.gov ↗ |
| DL39297 | Proposed LCD DL39297: Off-label Use of Rituximab and Rituximab Biosimilars | National Government Services | — | 1 | cms.gov ↗ |
| DL39314 | Proposed LCD DL39314: Off-Label Use of Intravenous Immune Globulin (IVIG) | National Government Services | — | 1 | cms.gov ↗ |
| DL39832 | Proposed LCD DL39832: Botulinum Toxin Injections | National Government Services | — | 1 | cms.gov ↗ |
| DL39836 | Proposed LCD DL39836: Botulinum Toxin Injections | Palmetto GBA | — | 1 | cms.gov ↗ |
| DL39857 | Proposed LCD DL39857: Botulinum Toxin Injections | CGS Administrators | — | 1 | cms.gov ↗ |
| DL39909 | Proposed LCD DL39909: Botulinum Toxin Injections | WPS | — | 1 | cms.gov ↗ |
| DL39923 | Proposed LCD DL39923: MolDX: Non-Next Generation Sequencing Tests for the Diagnosis of BCR-ABL Negative Myeloproliferative Neoplasms | Noridian | — | — | cms.gov ↗ |
| DL39927 | Proposed LCD DL39927: MolDX: Non-Next Generation Sequencing Tests for the Diagnosis of BCR-ABL Negative Myeloproliferative Neoplasms | Noridian | — | — | cms.gov ↗ |
| DL40000 | Proposed LCD DL40000: MolDX: Non-Next Generation Sequencing Tests for the Diagnosis of BCR-ABL Negative Myeloproliferative Neoplasms | CGS Administrators | — | — | cms.gov ↗ |
| DL40022 | Proposed LCD DL40022: MolDX: Non-Next Generation Sequencing Tests for the Diagnosis of BCR-ABL Negative Myeloproliferative Neoplasms | WPS | — | — | cms.gov ↗ |
| DL40048 | Proposed LCD DL40048: Allergen Immunotherapy (AIT) with Subcutaneous Immunotherapy (SCIT) | National Government Services | — | — | cms.gov ↗ |
| DL40050 | Proposed LCD DL40050: Allergen Immunotherapy (AIT) with Subcutaneous Immunotherapy (SCIT) | Noridian | — | 1 | cms.gov ↗ |
| DL40052 | Proposed LCD DL40052: Allergen Immunotherapy (AIT) with Subcutaneous Immunotherapy (SCIT) | Noridian | — | 1 | cms.gov ↗ |
| DL40058 | Proposed LCD DL40058: MolDX: Molecular Testing for Solid Organ Allograft Rejection | Palmetto GBA | — | 1 | cms.gov ↗ |
| DL40060 | Proposed LCD DL40060: MolDX: Molecular Testing for Solid Organ Allograft Rejection | Noridian | — | 1 | cms.gov ↗ |
| DL40062 | Proposed LCD DL40062: MolDX: Molecular Testing for Solid Organ Allograft Rejection | Noridian | — | 1 | cms.gov ↗ |
| DL40140 | Proposed LCD DL40140: MolDX: Molecular Testing for Solid Organ Allograft Rejection | CGS Administrators | — | 1 | cms.gov ↗ |
| DL40142 | Proposed LCD DL40142: MolDX: Biomarker Testing for Risk Stratification in DCIS | Palmetto GBA | — | 1 | cms.gov ↗ |
| DL40144 | Proposed LCD DL40144: MolDX: Biomarker Testing for Risk Stratification in DCIS | Noridian | — | 1 | cms.gov ↗ |
| DL40168 | Proposed LCD DL40168: Superficial Radiation Therapy (SRT) for the Treatment of Nonmelanoma Skin Cancers (NMSC) | National Government Services | — | 1 | cms.gov ↗ |
| DL40176 | Proposed LCD DL40176: Superficial Radiation Therapy (SRT) for the Treatment of Nonmelanoma Skin Cancers (NMSC) | Noridian | — | 1 | cms.gov ↗ |
| DL40179 | Proposed LCD DL40179: Superficial Radiation Therapy (SRT) for the Treatment of Nonmelanoma Skin Cancers (NMSC) | CGS Administrators | — | 1 | cms.gov ↗ |
| DL40187 | Proposed LCD DL40187: MolDX: Biomarker Testing for Risk Stratification in Metabolic Dysfunction-Associated Steatotic Liver Disease and Metabolic Dysfunction-Associated Steatohepatitis | Palmetto GBA | — | 1 | cms.gov ↗ |
| DL40189 | Proposed LCD DL40189: Superficial Radiation Therapy (SRT) for the Treatment of Nonmelanoma Skin Cancers (NMSC) | Palmetto GBA | — | 1 | cms.gov ↗ |
| DL40193 | Proposed LCD DL40193: Superficial Radiation Therapy (SRT) for the Treatment of Nonmelanoma Skin Cancers (NMSC) | WPS | — | 1 | cms.gov ↗ |
| DL40197 | Proposed LCD DL40197: MolDX: Biomarker Testing for Risk Stratification in Metabolic Dysfunction-Associated Steatotic Liver Disease and Metabolic Dysfunction-Associated Steatohepatitis | Noridian | — | 1 | cms.gov ↗ |
| DL40199 | Proposed LCD DL40199: MolDX: Biomarker Testing for Risk Stratification in Metabolic Dysfunction-Associated Steatotic Liver Disease and Metabolic Dysfunction-Associated Steatohepatitis | CGS Administrators | — | 1 | cms.gov ↗ |
| DL40205 | Proposed LCD DL40205: Irreversible Electroporation for Cancer | Palmetto GBA | — | 1 | cms.gov ↗ |
| DL40210 | Proposed LCD DL40210: MolDX: Non-Next Generation Sequencing Targeted Molecular Panel Tests for Predictive Testing in Cancer | Palmetto GBA | — | 1 | cms.gov ↗ |
| DL40222 | Proposed LCD DL40222: MolDX: Non-Next Generation Sequencing Targeted Molecular Panel Tests for Predictive Testing in Cancer | Noridian | — | 1 | cms.gov ↗ |
| DL40224 | Proposed LCD DL40224: Automated Detection and Quantification of Brain MRIs | CGS Administrators | — | 1 | cms.gov ↗ |
| DL40226 | Proposed LCD DL40226: MolDX: Non-Next Generation Sequencing Targeted Molecular Panel Tests for Predictive Testing in Cancer | CGS Administrators | — | 1 | cms.gov ↗ |
| DL40228 | Proposed LCD DL40228: Endovascular Management for Peripheral Arterial Disease of the Upper and Lower Extremities | Palmetto GBA | — | 1 | cms.gov ↗ |
| DL40232 | Proposed LCD DL40232: Total Joint Arthroplasty | CGS Administrators | — | 1 | cms.gov ↗ |
| DL40238 | Proposed LCD DL40238: MolDX: Genetic Testing for Hereditary Thrombophilia | Palmetto GBA | — | 1 | cms.gov ↗ |
| DL40242 | Proposed LCD DL40242: MolDX: Genetic Testing for Hereditary Thrombophilia | Noridian | — | 1 | cms.gov ↗ |
| DL40244 | Proposed LCD DL40244: Temporary Nontherapeutic Ambulatory Cardiac Monitoring Devices | CGS Administrators | — | 1 | cms.gov ↗ |
| DL40246 | Proposed LCD DL40246: MolDX: Biomarker Testing for Risk Stratification in DCIS | CGS Administrators | — | 1 | cms.gov ↗ |
| DL40249 | Proposed LCD DL40249: MolDX: Molecular Testing for Solid Organ Allograft Rejection | WPS | — | 1 | cms.gov ↗ |
| DL40251 | Proposed LCD DL40251: MolDX: Biomarker Testing for Risk Stratification in DCIS | WPS | — | 1 | cms.gov ↗ |
| DL40255 | Proposed LCD DL40255: Temporary Nontherapeutic Ambulatory Cardiac Monitoring Devices | Noridian | — | 1 | cms.gov ↗ |
| DL40257 | Proposed LCD DL40257: Temporary Nontherapeutic Ambulatory Cardiac Monitoring Devices | Palmetto GBA | — | 1 | cms.gov ↗ |
| DL40259 | Proposed LCD DL40259: MolDX: Genetic Testing for Hereditary Thrombophilia | CGS Administrators | — | 1 | cms.gov ↗ |
| DL40261 | Proposed LCD DL40261: Peripheral Nerve Blocks and Procedures for Chronic Pain | CGS Administrators | — | 1 | cms.gov ↗ |
| DL40263 | Proposed LCD DL40263: Peripheral Nerve Blocks and Procedures for Chronic Pain | Palmetto GBA | — | 1 | cms.gov ↗ |
| DL40265 | Proposed LCD DL40265: Peripheral Nerve Blocks and Procedures for Chronic Pain | Noridian | — | 1 | cms.gov ↗ |
| DL40267 | Proposed LCD DL40267: Peripheral Nerve Blocks and Procedures for Chronic Pain | National Government Services | — | 1 | cms.gov ↗ |
| DL40272 | Proposed LCD DL40272: MolDX: Biomarker Testing for Risk Stratification in Metabolic Dysfunction-Associated Steatotic Liver Disease and Metabolic Dysfunction-Associated Steatohepatitis | WPS | — | 1 | cms.gov ↗ |
| DL40274 | Proposed LCD DL40274: MolDX: Genetic Testing for Hereditary Thrombophilia | WPS | — | 1 | cms.gov ↗ |
| DL40276 | Proposed LCD DL40276: Non-invasive Arterial Duplex Ultrasound of the Upper and Lower Extremities | Novitas | — | 1 | cms.gov ↗ |
| DL40278 | Proposed LCD DL40278: MolDX: Non-Next Generation Sequencing Targeted Molecular Panel Tests for Predictive Testing in Cancer | WPS | — | 1 | cms.gov ↗ |
| DL40289 | Proposed LCD DL40289: Non-invasive Arterial Duplex Ultrasound of the Upper and Lower Extremities | First Coast | — | 1 | cms.gov ↗ |
| DL40300 | Proposed LCD DL40300: Peripheral Nerve Blocks and Procedures for Chronic Pain | WPS | — | 1 | cms.gov ↗ |
| DL40302 | Proposed LCD DL40302: Thermal Destruction of the Intraosseous Basivertebral Nerve (BVN) for Vertebrogenic Lower Back Pain | National Government Services | — | 1 | cms.gov ↗ |
| DL40324 | Proposed LCD DL40324: Allergy Diagnostic Testing | Noridian | — | 1 | cms.gov ↗ |
| DL40326 | Proposed LCD DL40326: Allergy Diagnostic Testing | CGS Administrators | — | 1 | cms.gov ↗ |
| DL40328 | Proposed LCD DL40328: Allergy Diagnostic Testing | Palmetto GBA | — | 1 | cms.gov ↗ |
| DL40330 | Proposed LCD DL40330: Allergy Diagnostic Testing | National Government Services | — | 1 | cms.gov ↗ |
| DL40332 | Proposed LCD DL40332: Automated Detection and Quantification of Brain MRIs | National Government Services | — | 1 | cms.gov ↗ |
| DL40334 | Proposed LCD DL40334: Erythropoiesis Stimulating Agents | National Government Services | — | 1 | cms.gov ↗ |
| DL40341 | Proposed LCD DL40341: Allergy Diagnostic Testing | WPS | — | 1 | cms.gov ↗ |
| DL40343 | Proposed LCD DL40343: Computed Tomography Cerebral Perfusion Analysis (CTP) | WPS | — | 1 | cms.gov ↗ |
| DL40356 | Proposed LCD DL40356: Anterior segment intraocular nonbiodegradable drug-eluting system | CGS Administrators | — | 1 | cms.gov ↗ |
| DL40359 | Proposed LCD DL40359: Anterior Segment Intraocular Nonbiodegradable Drug-eluting System | Noridian | — | 1 | cms.gov ↗ |
| DL40363 | Proposed LCD DL40363: Anterior segment intraocular nonbiodegradable drug-eluting system | National Government Services | — | 1 | cms.gov ↗ |
| DL40367 | Proposed LCD DL40367: Anterior segment intraocular nonbiodegradable drug-eluting system | Palmetto GBA | — | 1 | cms.gov ↗ |
| DL40378 | Proposed LCD DL40378: Urine-based Biomarkers in Patients with Microhematuria | Novitas | — | 1 | cms.gov ↗ |
| DL40380 | Proposed LCD DL40380: Urine-based Biomarkers in Patients with Microhematuria | First Coast | — | 1 | cms.gov ↗ |
| DL40385 | Proposed LCD DL40385: Anterior segment intraocular nonbiodegradable drug-eluting system | WPS | — | 1 | cms.gov ↗ |
| DL40407 | Proposed LCD DL40407: MolDX: Genome-Wide Molecular Methodologies for the Detection of Copy Number Alterations and Structural Variants in Hematologic Neoplasms | Palmetto GBA | — | 1 | cms.gov ↗ |
| DL40411 | Proposed LCD DL40411: MolDX: Genome-Wide Molecular Methodologies for the Detection of Copy Number Alterations and Structural Variants in Hematologic Neoplasms | Noridian | — | 1 | cms.gov ↗ |
| DL40425 | Proposed LCD DL40425: MolDX: Next-Generation Sequencing for Hematologic Malignancies and Suspected Hematologic Malignancies | Palmetto GBA | — | 1 | cms.gov ↗ |
| DL40427 | Proposed LCD DL40427: MolDX: Next-Generation Sequencing for Hematologic Malignancies and Suspected Hematologic Malignancies | Noridian | — | 1 | cms.gov ↗ |
| DL40429 | Proposed LCD DL40429: MolDX: Transcriptional Biomarkers for Therapeutic Decision-Making in Renal Carcinoma | Palmetto GBA | — | 1 | cms.gov ↗ |
| DL40431 | Proposed LCD DL40431: MolDX: Genome-Wide Molecular Methodologies for the Detection of Copy Number Alterations and Structural Variants in Hematologic Neoplasms | CGS Administrators | — | 2 | cms.gov ↗ |
| DL40433 | Proposed LCD DL40433: MolDX: Transcriptional Biomarkers for Therapeutic Decision-Making in Renal Carcinoma | CGS Administrators | — | 2 | cms.gov ↗ |
| DL40435 | Proposed LCD DL40435: MolDX: Transcriptional Biomarkers for Therapeutic Decision-Making in Renal Carcinoma | Noridian | — | 1 | cms.gov ↗ |
| DL40451 | Proposed LCD DL40451: MolDX: Next-Generation Sequencing for Hematologic Malignancies and Suspected Hematologic Malignancies | CGS Administrators | — | 2 | cms.gov ↗ |
“Versions held” counts distinct captured texts of the policy since capture began; a policy captured once has one. A “—” means the count could not be read on this load, not that none are held. How versions are captured and dated is on Methodology.